1248 Management LLC reduced its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 35.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,809 shares of the semiconductor company's stock after selling 977 shares during the quarter. 1248 Management LLC's holdings in Synopsys were worth $776,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of SNPS. Brighton Jones LLC boosted its position in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares during the period. Aptus Capital Advisors LLC grew its position in Synopsys by 58.1% during the fourth quarter. Aptus Capital Advisors LLC now owns 2,288 shares of the semiconductor company's stock valued at $1,111,000 after acquiring an additional 841 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Synopsys by 26.2% in the fourth quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company's stock worth $916,441,000 after purchasing an additional 391,681 shares during the last quarter. BNP Paribas boosted its holdings in Synopsys by 54.4% in the fourth quarter. BNP Paribas now owns 32,010 shares of the semiconductor company's stock valued at $15,537,000 after acquiring an additional 11,274 shares in the last quarter. Finally, Banque de Luxembourg S.A. bought a new stake in Synopsys in the fourth quarter valued at $6,237,000. 85.47% of the stock is currently owned by institutional investors.
Insider Activity
In related news, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the sale, the executive directly owned 1,485 shares of the company's stock, valued at $699,746.85. This trade represents a 85.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 7,310 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the sale, the chief financial officer directly owned 15,291 shares in the company, valued at approximately $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.
Analyst Ratings Changes
Several research firms have recently issued reports on SNPS. KeyCorp lifted their price target on Synopsys from $540.00 to $610.00 and gave the stock an "overweight" rating in a research report on Thursday, July 10th. Needham & Company LLC reiterated a "buy" rating and set a $660.00 price objective (up from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. Wells Fargo & Company reissued a "positive" rating on shares of Synopsys in a report on Wednesday. Morgan Stanley restated an "overweight" rating and set a $715.00 price target (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Finally, Rosenblatt Securities upped their price objective on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a research report on Friday, July 25th. Twelve research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $634.64.
Read Our Latest Research Report on Synopsys
Synopsys Stock Down 1.4%
Synopsys stock opened at $603.52 on Monday. The firm has a market cap of $93.64 billion, a price-to-earnings ratio of 43.58, a price-to-earnings-growth ratio of 3.97 and a beta of 1.14. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The business's 50-day moving average price is $583.07 and its 200 day moving average price is $503.25. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.